This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy
Ticker(s): CLRBWho's the expert?
Can you try to get the investigators of this study on a call to better understand how this study would have compared to without using 131?
Interview GoalCan you try to get the investigators of this study on a call to better understand how this study would have compared to without using 131?https://investor.cellectar.com/press-releases/detail/328/cellectar-biosciences-reports-high-rate-of-...
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
